Logo 1 Logo 2

Clinical Trial Details

Trial ID: L5322
Source ID: NCT00849342
Associated Drug: Insulin Detemir
Title: Observational Study on LevemirĀ® in Obese Diabetic Patients
Acronym: KILOS
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
Interventions: DRUG: insulin detemir
Outcome Measures: Primary: Change in body weight and BMI, during 12 months of treatment | Secondary: Change in body weight at different BMI subgroups, at insulin start, 12 and 6 months before treatment and after 3, 6, 9 and 12 months of treatment|Change in waist perimeter, from insulin start and after 6 and 12 months of treatment|Change in FPG (Fasting Plasma Glucose), from 12 and 6 months before treatment after 6 and 12 months of treatment|Change in HbA1C, from insulin start and 12 and 6 months before treatment and after 6 and 12 months of treatment|Change in number of hypoglycaemic events during 4 weeks proceeding routine visits, after 6 and 12 months of treatment|Number of adverse drug reactions (ADR), after 6 and 12 months of treatment|Change in blood pressure, from insulin start and 6 and 12 months after treatment
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: CHILD, ADULT, OLDER_ADULT
Phases:
Enrollment: 580
Study Type: OBSERVATIONAL
Study Designs: Observational Model: |Time Perspective: p
Start Date: 2008-12
Completion Date: 2013-01
Results First Posted:
Last Update Posted: 2014-08-15
Locations: Alphen a/d Rijn, Netherlands|Ljubljana, SI-1000, Slovenia
URL: https://clinicaltrials.gov/show/NCT00849342